{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:52:07Z","timestamp":1791341527152,"version":"4.3.1"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000048","name":"American Cancer Society Inc","doi-asserted-by":"publisher","award":["RSG-19079-01-TBG"],"award-info":[{"award-number":["RSG-19079-01-TBG"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DP1DA054344"],"award-info":[{"award-number":["DP1DA054344"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DE033906"],"award-info":[{"award-number":["R01DE033906"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.canlet.2026.218840","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T06:01:02Z","timestamp":1789365662000},"page":"218840","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Epithelial HSD11\u03b22 as an immunometabolic checkpoint in head and neck cancer: Restoring local steroid inactivation reinvigorates T cell immunity"],"prefix":"10.1016","volume":"660","author":[{"given":"Felipe F.","family":"Lamenza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puja","family":"Upadhaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8255-5936","authenticated-orcid":false,"given":"Ravi","family":"Ramalingam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushmitha","family":"Jagadeesha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suvekshya","family":"Shrestha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reegan","family":"Kehres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Kazmierowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonali","family":"Dasari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaheer","family":"Masood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kishan Kumar","family":"Nyati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peyton","family":"Roth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Horn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan","family":"Pracha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6291-1457","authenticated-orcid":false,"given":"Arham","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaokui","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Iwenofu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5177-0652","authenticated-orcid":false,"given":"Steve","family":"Oghumu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.canlet.2026.218840_bib1","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41572-020-00224-3","article-title":"Head and neck squamous cell carcinoma","volume":"6","author":"Johnson","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.canlet.2026.218840_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2022.101426","article-title":"Therapeutic approaches for the treatment of head and neck squamous cell carcinoma-An update on clinical trials","volume":"21","author":"Goel","year":"2022","journal-title":"Transl. Oncol."},{"issue":"1","key":"10.1016\/j.canlet.2026.218840_bib3","doi-asserted-by":"crossref","first-page":"5985","DOI":"10.1038\/s41598-025-89053-6","article-title":"Survival and data-driven phenotypes in head and neck cancer","volume":"15","author":"Heinolainen","year":"2025","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.canlet.2026.218840_bib4","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2025.2477872","article-title":"Efficacy of anti-LAG3 and anti-PD-1 combination checkpoint inhibitor therapy against head and neck squamous cell carcinoma in a genetically engineered mouse model","volume":"14","author":"Lamenza","year":"2025","journal-title":"Oncoimmunology"},{"issue":"11","key":"10.1016\/j.canlet.2026.218840_bib5","first-page":"3282","article-title":"Smoking and drinking in relation to oral and pharyngeal cancer","volume":"48","author":"Blot","year":"1988","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.canlet.2026.218840_bib6","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/hed.22015","article-title":"Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer--systematic review and meta-analysis of trends by time and region","volume":"35","author":"Mehanna","year":"2013","journal-title":"Head Neck"},{"issue":"7","key":"10.1016\/j.canlet.2026.218840_bib7","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1002\/ijc.28811","article-title":"High-risk HPV types and head and neck cancer","volume":"135","author":"Michaud","year":"2014","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.canlet.2026.218840_bib8","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.immuni.2020.08.005","article-title":"Endogenous glucocorticoid signaling regulates CD8(+) T cell differentiation and development of dysfunction in the tumor microenvironment","volume":"53","author":"Acharya","year":"2020","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.canlet.2026.218840_bib9","doi-asserted-by":"crossref","first-page":"3588","DOI":"10.1038\/s41467-020-17339-6","article-title":"Tumors induce de novo steroid biosynthesis in T cells to evade immunity","volume":"11","author":"Mahata","year":"2020","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.canlet.2026.218840_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2026.117367","article-title":"Glucocorticoid receptor and RUNX transcription factors cooperatively drive CD8 T cell dysfunction in human cancer","volume":"45","author":"Ward","year":"2026","journal-title":"Cell Rep."},{"issue":"4","key":"10.1016\/j.canlet.2026.218840_bib11","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/s41577-020-00464-0","article-title":"Glucocorticoids in T cell development, differentiation and function","volume":"21","author":"Taves","year":"2021","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.canlet.2026.218840_bib12","first-page":"55","article-title":"How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions","volume":"21","author":"Sapolsky","year":"2000","journal-title":"Endocr. Rev."},{"issue":"6","key":"10.1016\/j.canlet.2026.218840_bib13","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1042\/cs0940557","article-title":"Anti-inflammatory actions of glucocorticoids: molecular mechanisms","volume":"94","author":"Barnes","year":"1998","journal-title":"Clin. Sci. (Lond.)"},{"issue":"4","key":"10.1016\/j.canlet.2026.218840_bib14","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nri.2017.1","article-title":"Immune regulation by glucocorticoids","volume":"17","author":"Cain","year":"2017","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.canlet.2026.218840_bib15","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1515\/jtim-2016-0011","article-title":"A little help from steroids in oncology","volume":"4","author":"Lossignol","year":"2016","journal-title":"J Transl Int Med"},{"issue":"6","key":"10.1016\/j.canlet.2026.218840_bib16","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.coph.2004.09.001","article-title":"11beta-hydroxysteroid dehydrogenases: changing glucocorticoid action","volume":"4","author":"Seckl","year":"2004","journal-title":"Curr. Opin. Pharmacol."},{"issue":"2","key":"10.1016\/j.canlet.2026.218840_bib17","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1677\/joe.1.06019","article-title":"11beta-hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action","volume":"186","author":"Draper","year":"2005","journal-title":"J. Endocrinol."},{"issue":"1","key":"10.1016\/j.canlet.2026.218840_bib18","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/carcin\/bgab118","article-title":"Modulation of the oral glucocorticoid system during black raspberry mediated oral cancer chemoprevention","volume":"43","author":"Nedungadi","year":"2022","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/j.canlet.2026.218840_bib19","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/0022034511427909","article-title":"Characterization of a novel oral glucocorticoid system and its possible role in disease","volume":"91","author":"Cirillo","year":"2012","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.canlet.2026.218840_bib20","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.steroids.2015.06.010","article-title":"Local glucocorticoid production in the thymus","volume":"103","author":"Talaber","year":"2015","journal-title":"Steroids"},{"key":"10.1016\/j.canlet.2026.218840_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cellimm.2018.08.009","article-title":"Local synthesis of immunosuppressive glucocorticoids in the intestinal epithelium regulates anti-viral immune responses","volume":"334","author":"Huang","year":"2018","journal-title":"Cell. Immunol."},{"issue":"1","key":"10.1016\/j.canlet.2026.218840_bib22","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/s13046-018-0929-6","article-title":"Apigenin suppresses PD-L1 expression in melanoma and host dendritic cells to elicit synergistic therapeutic effects","volume":"37","author":"Xu","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1a","key":"10.1016\/j.canlet.2026.218840_bib23","first-page":"413","article-title":"Apigenin inhibits growth and induces G2\/M arrest by modulating cyclin-CDK regulators and ERK MAP kinase activation in breast carcinoma cells","volume":"21","author":"Yin","year":"2001","journal-title":"Anticancer Res."},{"issue":"9","key":"10.1016\/j.canlet.2026.218840_bib24","first-page":"1","article-title":"Flavonoids: a versatile source of anticancer drugs","volume":"5","author":"Chahar","year":"2011","journal-title":"Pharmacogn. Rev."},{"issue":"2","key":"10.1016\/j.canlet.2026.218840_bib25","first-page":"488","article-title":"Apigenin inhibits in vitro and in vivo tumorigenesis in cisplatin-resistant colon cancer cells by inducing autophagy, programmed cell death and targeting m-TOR\/PI3K\/Akt signalling pathway","volume":"24","author":"Chen","year":"2019","journal-title":"J. Buon"},{"issue":"4","key":"10.1016\/j.canlet.2026.218840_bib26","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1089\/thy.1999.9.369","article-title":"Growth inhibitory effects of flavonoids in human thyroid cancer cell lines","volume":"9","author":"Yin","year":"1999","journal-title":"Thyroid"},{"issue":"11","key":"10.1016\/j.canlet.2026.218840_bib27","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1271\/bbb.62.2199","article-title":"Structure-activity relationships of flavonoids and the induction of granulocytic- or monocytic-differentiation in HL60 human myeloid leukemia cells","volume":"62","author":"Takahashi","year":"1998","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"10.1016\/j.canlet.2026.218840_bib28","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1476-4598-5-76","article-title":"Apigenin inhibits pancreatic cancer cell proliferation through G2\/M cell cycle arrest","volume":"5","author":"Ujiki","year":"2006","journal-title":"Mol. Cancer"},{"issue":"9","key":"10.1016\/j.canlet.2026.218840_bib29","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1158\/1541-7786.MCR-13-0084-T","article-title":"Epithelial-specific deletion of 11\u03b2-HSD2 hinders Apcmin\/+ mouse tumorigenesis","volume":"11","author":"Jiang","year":"2013","journal-title":"Mol. Cancer Res."},{"issue":"8","key":"10.1016\/j.canlet.2026.218840_bib30","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/s41417-023-00629-8","article-title":"Inducible TgfbR1 and Pten deletion in a model of tongue carcinogenesis and chemoprevention","volume":"30","author":"Lamenza","year":"2023","journal-title":"Cancer Gene Ther."},{"issue":"5","key":"10.1016\/j.canlet.2026.218840_bib31","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.2144\/01315rr05","article-title":"Genotyping of Cre-lox mice and detection of tissue-specific recombination by multiplex PCR","volume":"31","author":"Leneuve","year":"2001","journal-title":"Biotechniques"},{"issue":"4","key":"10.1016\/j.canlet.2026.218840_bib32","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/s41416-022-01853-z","article-title":"STAT1 is regulated by TRIM24 and promotes immunosuppression in head and neck squamous carcinoma cells, but enhances T cell antitumour immunity in the tumour microenvironment","volume":"127","author":"Anderson","year":"2022","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2026.218840_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2024.107126","article-title":"Targeting macrophage migration inhibitory factor to inhibit T cell immunosuppression in the tumor microenvironment and improve cancer outcomes in head and neck squamous cell carcinoma","volume":"160","author":"Pracha","year":"2025","journal-title":"Oral Oncol."},{"issue":"7","key":"10.1016\/j.canlet.2026.218840_bib34","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00262-025-04081-5","article-title":"Inhibition of head and neck squamous cell carcinoma by Bruton's tyrosine kinase inhibitor ibrutinib is associated with reduction of immunosuppressive T cells","volume":"74","author":"Bopp","year":"2025","journal-title":"Cancer Immunol. Immunother."},{"issue":"6","key":"10.1016\/j.canlet.2026.218840_bib35","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1002\/ijc.32781","article-title":"STAT1 inhibits T-cell exhaustion and myeloid derived suppressor cell accumulation to promote antitumor immune responses in head and neck squamous cell carcinoma","volume":"146","author":"Ryan","year":"2020","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.canlet.2026.218840_bib36","doi-asserted-by":"crossref","DOI":"10.1080\/15384047.2025.2600701","article-title":"PI3K\u03b3 inhibition drives M1 macrophage differentiation and synergizes with PD-L1 blockade to improve survival in poorly immunogenic head and neck squamous cell carcinoma","volume":"27","author":"Jordanides","year":"2026","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.canlet.2026.218840_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2026.107929","article-title":"Sex-based immune differences influence tumor progression in head and neck squamous cell carcinoma","volume":"176","author":"Jagadeesha","year":"2026","journal-title":"Oral Oncol."},{"key":"10.1016\/j.canlet.2026.218840_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.932742","article-title":"Black raspberry extract inhibits regulatory T-cell activity in a murine model of head and neck squamous cell carcinoma chemoprevention","volume":"13","author":"Ryan","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.canlet.2026.218840_bib39","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"edgeR: a Bioconductor package for differential expression analysis of digital gene expression data","volume":"26","author":"Robinson","year":"2010","journal-title":"Bioinformatics"},{"issue":"5","key":"10.1016\/j.canlet.2026.218840_bib40","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS A J. Integr. Biol."},{"issue":"1","key":"10.1016\/j.canlet.2026.218840_bib41","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.prro.2022.07.003","article-title":"Use of glucocorticoids in patients with cancer: potential benefits, harms, and practical considerations for clinical practice","volume":"13","author":"Kim","year":"2023","journal-title":"Pract Radiat Oncol"},{"issue":"3","key":"10.1016\/j.canlet.2026.218840_bib42","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/ijc.21743","article-title":"Glucocorticoids interfere with therapeutic efficacy of paclitaxel against human breast and ovarian xenograft tumors","volume":"119","author":"Sui","year":"2006","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.canlet.2026.218840_bib43","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1002\/jcp.27227","article-title":"Glucocorticoids reduce chemotherapeutic effectiveness on OSCC cells via glucose-dependent mechanisms","volume":"234","author":"Celentano","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"6","key":"10.1016\/j.canlet.2026.218840_bib44","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/sj.bjc.6602453","article-title":"Dexamethasone-induced cisplatin and gemcitabine resistance in lung carcinoma samples treated ex vivo","volume":"92","author":"Gassler","year":"2005","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.canlet.2026.218840_bib45","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.canlet.2005.10.037","article-title":"Dexamethasone desensitizes hepatocellular and colorectal tumours toward cytotoxic therapy","volume":"242","author":"Zhang","year":"2006","journal-title":"Cancer Lett."},{"issue":"10","key":"10.1016\/j.canlet.2026.218840_bib46","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1136\/jclinpath-2012-200695","article-title":"Increased plasma and salivary cortisol levels in patients with oral cancer and their association with clinical stage","volume":"65","author":"Bernabe","year":"2012","journal-title":"J. Clin. Pathol."},{"issue":"10","key":"10.1016\/j.canlet.2026.218840_bib47","doi-asserted-by":"crossref","first-page":"6128","DOI":"10.21037\/tcr-20-1465","article-title":"ZC3H12D is a prognostic biomarker associated with immune cell infiltration in lung adenocarcinoma","volume":"9","author":"Gong","year":"2020","journal-title":"Transl. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218840_bib48","doi-asserted-by":"crossref","first-page":"232","DOI":"10.2174\/1874312901206010232","article-title":"JAK kinases in health and disease: an update","volume":"6","author":"Laurence","year":"2012","journal-title":"Open Rheumatol. J."},{"issue":"3","key":"10.1016\/j.canlet.2026.218840_bib49","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.4049\/jimmunol.182.3.1429","article-title":"Endogenously produced IL-4 nonredundantly stimulates CD8+ T cell proliferation","volume":"182","author":"Morris","year":"2009","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.canlet.2026.218840_bib50","doi-asserted-by":"crossref","first-page":"684","DOI":"10.4049\/jimmunol.1800697","article-title":"High-dose IL-2 skews a glucocorticoid-driven IL-17(+)IL-10(+) memory CD4(+) T cell response towards a single IL-10-Producing phenotype","volume":"202","author":"Mann","year":"2019","journal-title":"J. Immunol."},{"issue":"28","key":"10.1016\/j.canlet.2026.218840_bib51","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1200\/JCO.2018.79.0006","article-title":"Impact of baseline steroids on efficacy of programmed cell Death-1 and programmed death-ligand 1 blockade in patients with non-small-cell lung cancer","volume":"36","author":"Arbour","year":"2018","journal-title":"J. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.canlet.2026.218840_bib52","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25105569","article-title":"Apigenin: molecular mechanisms and therapeutic potential against cancer spreading","volume":"25","author":"Naponelli","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.canlet.2026.218840_bib53","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1007\/s11095-010-0089-7","article-title":"Apigenin: a promising molecule for cancer prevention","volume":"27","author":"Shukla","year":"2010","journal-title":"Pharm. Res."},{"issue":"7","key":"10.1016\/j.canlet.2026.218840_bib54","doi-asserted-by":"crossref","first-page":"971","DOI":"10.2174\/18715206113139990119","article-title":"Targeting the PI3K\/Akt\/mTOR axis by apigenin for cancer prevention","volume":"13","author":"Tong","year":"2013","journal-title":"Anti Cancer Agents Med. Chem."},{"issue":"11\u201312","key":"10.1016\/j.canlet.2026.218840_bib55","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.steroids.2006.09.001","article-title":"Type 2 11beta-hydroxysteroid dehydrogenase activity in human ovarian cancer","volume":"71","author":"Temkin","year":"2006","journal-title":"Steroids"},{"issue":"2","key":"10.1016\/j.canlet.2026.218840_bib56","first-page":"662","article-title":"Type-2 11\u03b2-hydroxysteroid dehydrogenase promotes the metastasis of colorectal cancer via the Fgfbp1-AKT pathway","volume":"10","author":"Chen","year":"2020","journal-title":"Am. J. Cancer Res."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030438352600604X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030438352600604X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:20:10Z","timestamp":1791339610000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030438352600604X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":56,"alternative-id":["S030438352600604X"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218840","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epithelial HSD11\u03b22 as an immunometabolic checkpoint in head and neck cancer: Restoring local steroid inactivation reinvigorates T cell immunity","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218840","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"218840"}}